APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Central Vascular Access Device

Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).

Selected research

Market Outlook & Growth Opportunities

Global Central Vascular Access Device Market Outlook and Growth Opportunities 2026

Report ID 173900420421 December 2025191 pages

Choose your research edition.

Industry ResearchCentral Vascular Access Device Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Central Vascular Access Device Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Central Vascular Access Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Central Vascular Access Device Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Central Vascular Access Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).

Global Central Vascular Access Device key players include C. R. Bard, Inc., Teleflex Incorporated, Terumo Corporation, etc. Global top three manufacturers hold a share nearly 55%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share about 50 percent.

Read the full market overview

In terms of product, PICC is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospital, followed by Non-Hospital.

This report provides an overview of the global Central Vascular Access Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Central Vascular Access Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Central Vascular Access Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Central Vascular Access Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Central Vascular Access Device Segment by Company

Becton Dickinson

C. R. Bard, Inc.

Smiths Medical, Inc

Teleflex Incorporated

B.Braun

NIPRO Medical Corporation

Edwards Lifesciences Corporation

Terumo Corporation

Vygon Ltd.

Ameco Medical

AngioDynamics

Romsons

PRODIMED

Central Vascular Access Device Segment by Type

PICC

Centrally Inserted Catheters

Implanted Ports

Other

Central Vascular Access Device Segment by Application

Hospital

Non-Hospital

Central Vascular Access Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Central Vascular Access Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Central Vascular Access Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Central Vascular Access Device significant trends, drivers, influence factors in global and regions.

6. To analyze Central Vascular Access Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Central Vascular Access Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Central Vascular Access Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Central Vascular Access Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Central Vascular Access Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Central Vascular Access Device industry.

Chapter 3: Detailed analysis of Central Vascular Access Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Central Vascular Access Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Central Vascular Access Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Central Vascular Access Device Industry Trends Table 2. Central Vascular Access Device Industry Drivers Table 3. Central Vascular Access Device Industry Opportunities and Challenges Table 4. Central Vascular Access Device Industry Restraints Table 5. Global Central Vascular Access Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Central Vascular Access Device Revenue Share by Company (2021-2026) Table 7. Global Central Vascular Access Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Central Vascular Access Device Sales Volume Share by Company (2021-2026) Table 9. Global Central Vascular Access Device Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Central Vascular Access Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Central Vascular Access Device Key Company Manufacturing Base & Headquarters Table 12. Global Central Vascular Access Device Company, Product Type & Application Table 13. Global Central Vascular Access Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Central Vascular Access Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PICC Table 18. Significant Companies of Centrally Inserted Catheters Table 19. Significant Companies of Implanted Ports Table 20. Significant Companies of Other Table 21. Global Central Vascular Access Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Central Vascular Access Device Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Central Vascular Access Device Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Central Vascular Access Device Sales Volume Share by Type (2021-2026) Table 25. Global Central Vascular Access Device Sales Volume Share by Type (2027-2032) Table 26. Global Central Vascular Access Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Central Vascular Access Device Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Central Vascular Access Device Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Central Vascular Access Device Sales Value Share by Type (2021-2026) Table 30. Global Central Vascular Access Device Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Non-Hospital Table 33. Global Central Vascular Access Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Central Vascular Access Device Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Central Vascular Access Device Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Central Vascular Access Device Sales Volume Share by Application (2021-2026) Table 37. Global Central Vascular Access Device Sales Volume Share by Application (2027-2032) Table 38. Global Central Vascular Access Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Central Vascular Access Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Central Vascular Access Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Central Vascular Access Device Sales Value Share by Application (2021-2026) Table 42. Global Central Vascular Access Device Sales Value Share by Application (2027-2032) Table 43. Global Central Vascular Access Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Central Vascular Access Device Sales by Region (2021-2026) & (K Units) Table 45. Global Central Vascular Access Device Sales Market Share by Region (2021-2026) Table 46. Global Central Vascular Access Device Sales by Region (2027-2032) & (K Units) Table 47. Global Central Vascular Access Device Sales Market Share by Region (2027-2032) Table 48. Global Central Vascular Access Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Central Vascular Access Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Central Vascular Access Device Sales Value Share by Region (2021-2026) Table 51. Global Central Vascular Access Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Central Vascular Access Device Sales Value Share by Region (2027-2032) Table 53. Global Central Vascular Access Device Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Central Vascular Access Device Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Central Vascular Access Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Central Vascular Access Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Central Vascular Access Device Sales by Country (2021-2026) & (K Units) Table 58. Global Central Vascular Access Device Sales Market Share by Country (2021-2026) Table 59. Global Central Vascular Access Device Sales by Country (2027-2032) & (K Units) Table 60. Global Central Vascular Access Device Sales Market Share by Country (2027-2032) Table 61. Global Central Vascular Access Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Central Vascular Access Device Sales Value Market Share by Country (2021-2026) Table 63. Global Central Vascular Access Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Central Vascular Access Device Sales Value Market Share by Country (2027-2032) Table 65. Becton Dickinson Company Information Table 66. Becton Dickinson Business Overview Table 67. Becton Dickinson Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Becton Dickinson Central Vascular Access Device Product Portfolio Table 69. Becton Dickinson Recent Development Table 70. C. R. Bard, Inc. Company Information Table 71. C. R. Bard, Inc. Business Overview Table 72. C. R. Bard, Inc. Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. C. R. Bard, Inc. Central Vascular Access Device Product Portfolio Table 74. C. R. Bard, Inc. Recent Development Table 75. Smiths Medical, Inc Company Information Table 76. Smiths Medical, Inc Business Overview Table 77. Smiths Medical, Inc Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Smiths Medical, Inc Central Vascular Access Device Product Portfolio Table 79. Smiths Medical, Inc Recent Development Table 80. Teleflex Incorporated Company Information Table 81. Teleflex Incorporated Business Overview Table 82. Teleflex Incorporated Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Teleflex Incorporated Central Vascular Access Device Product Portfolio Table 84. Teleflex Incorporated Recent Development Table 85. B.Braun Company Information Table 86. B.Braun Business Overview Table 87. B.Braun Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. B.Braun Central Vascular Access Device Product Portfolio Table 89. B.Braun Recent Development Table 90. NIPRO Medical Corporation Company Information Table 91. NIPRO Medical Corporation Business Overview Table 92. NIPRO Medical Corporation Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. NIPRO Medical Corporation Central Vascular Access Device Product Portfolio Table 94. NIPRO Medical Corporation Recent Development Table 95. Edwards Lifesciences Corporation Company Information Table 96. Edwards Lifesciences Corporation Business Overview Table 97. Edwards Lifesciences Corporation Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Edwards Lifesciences Corporation Central Vascular Access Device Product Portfolio Table 99. Edwards Lifesciences Corporation Recent Development Table 100. Terumo Corporation Company Information Table 101. Terumo Corporation Business Overview Table 102. Terumo Corporation Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Terumo Corporation Central Vascular Access Device Product Portfolio Table 104. Terumo Corporation Recent Development Table 105. Vygon Ltd. Company Information Table 106. Vygon Ltd. Business Overview Table 107. Vygon Ltd. Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Vygon Ltd. Central Vascular Access Device Product Portfolio Table 109. Vygon Ltd. Recent Development Table 110. Ameco Medical Company Information Table 111. Ameco Medical Business Overview Table 112. Ameco Medical Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Ameco Medical Central Vascular Access Device Product Portfolio Table 114. Ameco Medical Recent Development Table 115. AngioDynamics Company Information Table 116. AngioDynamics Business Overview Table 117. AngioDynamics Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. AngioDynamics Central Vascular Access Device Product Portfolio Table 119. AngioDynamics Recent Development Table 120. Romsons Company Information Table 121. Romsons Business Overview Table 122. Romsons Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Romsons Central Vascular Access Device Product Portfolio Table 124. Romsons Recent Development Table 125. PRODIMED Company Information Table 126. PRODIMED Business Overview Table 127. PRODIMED Central Vascular Access Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. PRODIMED Central Vascular Access Device Product Portfolio Table 129. PRODIMED Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Central Vascular Access Device Distributors List Table 133. Central Vascular Access Device Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Central Vascular Access Device Product Image Figure 2. Global Central Vascular Access Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Central Vascular Access Device Sales (2021-2032) & (K Units) Figure 5. Global Central Vascular Access Device Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Central Vascular Access Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PICC Image Figure 10. Centrally Inserted Catheters Image Figure 11. Implanted Ports Image Figure 12. Other Image Figure 13. Global Central Vascular Access Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Central Vascular Access Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Central Vascular Access Device Sales Volume Share by Type (2021-2032) Figure 16. Global Central Vascular Access Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Central Vascular Access Device Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Central Vascular Access Device Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Non-Hospital Image Figure 21. Global Central Vascular Access Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Central Vascular Access Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Central Vascular Access Device Sales Volume Share by Application (2021-2032) Figure 24. Global Central Vascular Access Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Central Vascular Access Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Central Vascular Access Device Sales Value Share by Application (2021-2032) Figure 27. Global Central Vascular Access Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Central Vascular Access Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Central Vascular Access Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Central Vascular Access Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Central Vascular Access Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Central Vascular Access Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Central Vascular Access Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Central Vascular Access Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Central Vascular Access Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Central Vascular Access Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Central Vascular Access Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Central Vascular Access Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Central Vascular Access Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • PICC
  • Centrally Inserted Catheters
  • Implanted Ports
  • Other
Applications
  • Hospital
  • Non-Hospital
Companies covered
  • Becton Dickinson
  • C. R. Bard, Inc.
  • Smiths Medical, Inc
  • Teleflex Incorporated
  • B.Braun
  • NIPRO Medical Corporation
  • Edwards Lifesciences Corporation
  • Terumo Corporation
  • Vygon Ltd.
  • Ameco Medical
  • AngioDynamics
  • Romsons
  • PRODIMED

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Central Vascular Access Device Sales Value (2021-2032)
  4. 1.2.2 Global Central Vascular Access Device Sales Volume (2021-2032)
  5. 1.2.3 Global Central Vascular Access Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Central Vascular Access Device Market Dynamics
  1. 2.1 Central Vascular Access Device Industry Trends
  2. 2.2 Central Vascular Access Device Industry Drivers
  3. 2.3 Central Vascular Access Device Industry Opportunities and Challenges
  4. 2.4 Central Vascular Access Device Industry Restraints
3 Central Vascular Access Device Market by Company
  1. 3.1 Global Central Vascular Access Device Company Revenue Ranking in 2025
  2. 3.2 Global Central Vascular Access Device Revenue by Company (2021-2026)
  3. 3.3 Global Central Vascular Access Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Central Vascular Access Device Average Price by Company (2021-2026)
  5. 3.5 Global Central Vascular Access Device Company Ranking (2024-2026)
  6. 3.6 Global Central Vascular Access Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Central Vascular Access Device Company Product Type and Application
  8. 3.8 Global Central Vascular Access Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Central Vascular Access Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Central Vascular Access Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Central Vascular Access Device Market by Type
  1. 4.1 Central Vascular Access Device Type Introduction
  2. 4.1.1 PICC
  3. 4.1.2 Centrally Inserted Catheters
  4. 4.1.3 Implanted Ports
  5. 4.1.4 Other
  6. 4.2 Global Central Vascular Access Device Sales Volume by Type
  7. 4.2.1 Global Central Vascular Access Device Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Central Vascular Access Device Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Central Vascular Access Device Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Central Vascular Access Device Sales Value by Type
  11. 4.3.1 Global Central Vascular Access Device Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Central Vascular Access Device Sales Value by Type (2021-2032)
  13. 4.3.3 Global Central Vascular Access Device Sales Value Share by Type (2021-2032)
5 Central Vascular Access Device Market by Application
  1. 5.1 Central Vascular Access Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Non-Hospital
  4. 5.2 Global Central Vascular Access Device Sales Volume by Application
  5. 5.2.1 Global Central Vascular Access Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Central Vascular Access Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Central Vascular Access Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Central Vascular Access Device Sales Value by Application
  9. 5.3.1 Global Central Vascular Access Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Central Vascular Access Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Central Vascular Access Device Sales Value Share by Application (2021-2032)
6 Central Vascular Access Device Regional Sales and Value Analysis
  1. 6.1 Global Central Vascular Access Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Central Vascular Access Device Sales by Region (2021-2032)
  3. 6.2.1 Global Central Vascular Access Device Sales by Region: 2021-2026
  4. 6.2.2 Global Central Vascular Access Device Sales by Region (2027-2032)
  5. 6.3 Global Central Vascular Access Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Central Vascular Access Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Central Vascular Access Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Central Vascular Access Device Sales Value by Region (2027-2032)
  9. 6.5 Global Central Vascular Access Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Central Vascular Access Device Sales Value (2021-2032)
  12. 6.6.2 North America Central Vascular Access Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Central Vascular Access Device Sales Value (2021-2032)
  15. 6.7.2 Europe Central Vascular Access Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Central Vascular Access Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Central Vascular Access Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Central Vascular Access Device Sales Value (2021-2032)
  21. 6.9.2 South America Central Vascular Access Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Central Vascular Access Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Central Vascular Access Device Sales Value Share by Country, 2025 VS 2032
7 Central Vascular Access Device Country-level Sales and Value Analysis
  1. 7.1 Global Central Vascular Access Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Central Vascular Access Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Central Vascular Access Device Sales by Country (2021-2032)
  4. 7.3.1 Global Central Vascular Access Device Sales by Country (2021-2026)
  5. 7.3.2 Global Central Vascular Access Device Sales by Country (2027-2032)
  6. 7.4 Global Central Vascular Access Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Central Vascular Access Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Central Vascular Access Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Central Vascular Access Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Central Vascular Access Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Central Vascular Access Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton Dickinson
  2. 8.1.1 Becton Dickinson Company Information
  3. 8.1.2 Becton Dickinson Business Overview
  4. 8.1.3 Becton Dickinson Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Becton Dickinson Central Vascular Access Device Product Portfolio
  6. 8.1.5 Becton Dickinson Recent Developments
  7. 8.2 C. R. Bard, Inc.
  8. 8.2.1 C. R. Bard, Inc. Company Information
  9. 8.2.2 C. R. Bard, Inc. Business Overview
  10. 8.2.3 C. R. Bard, Inc. Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 C. R. Bard, Inc. Central Vascular Access Device Product Portfolio
  12. 8.2.5 C. R. Bard, Inc. Recent Developments
  13. 8.3 Smiths Medical, Inc
  14. 8.3.1 Smiths Medical, Inc Company Information
  15. 8.3.2 Smiths Medical, Inc Business Overview
  16. 8.3.3 Smiths Medical, Inc Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Smiths Medical, Inc Central Vascular Access Device Product Portfolio
  18. 8.3.5 Smiths Medical, Inc Recent Developments
  19. 8.4 Teleflex Incorporated
  20. 8.4.1 Teleflex Incorporated Company Information
  21. 8.4.2 Teleflex Incorporated Business Overview
  22. 8.4.3 Teleflex Incorporated Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Teleflex Incorporated Central Vascular Access Device Product Portfolio
  24. 8.4.5 Teleflex Incorporated Recent Developments
  25. 8.5 B.Braun
  26. 8.5.1 B.Braun Company Information
  27. 8.5.2 B.Braun Business Overview
  28. 8.5.3 B.Braun Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B.Braun Central Vascular Access Device Product Portfolio
  30. 8.5.5 B.Braun Recent Developments
  31. 8.6 NIPRO Medical Corporation
  32. 8.6.1 NIPRO Medical Corporation Company Information
  33. 8.6.2 NIPRO Medical Corporation Business Overview
  34. 8.6.3 NIPRO Medical Corporation Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NIPRO Medical Corporation Central Vascular Access Device Product Portfolio
  36. 8.6.5 NIPRO Medical Corporation Recent Developments
  37. 8.7 Edwards Lifesciences Corporation
  38. 8.7.1 Edwards Lifesciences Corporation Company Information
  39. 8.7.2 Edwards Lifesciences Corporation Business Overview
  40. 8.7.3 Edwards Lifesciences Corporation Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Edwards Lifesciences Corporation Central Vascular Access Device Product Portfolio
  42. 8.7.5 Edwards Lifesciences Corporation Recent Developments
  43. 8.8 Terumo Corporation
  44. 8.8.1 Terumo Corporation Company Information
  45. 8.8.2 Terumo Corporation Business Overview
  46. 8.8.3 Terumo Corporation Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Terumo Corporation Central Vascular Access Device Product Portfolio
  48. 8.8.5 Terumo Corporation Recent Developments
  49. 8.9 Vygon Ltd.
  50. 8.9.1 Vygon Ltd. Company Information
  51. 8.9.2 Vygon Ltd. Business Overview
  52. 8.9.3 Vygon Ltd. Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vygon Ltd. Central Vascular Access Device Product Portfolio
  54. 8.9.5 Vygon Ltd. Recent Developments
  55. 8.10 Ameco Medical
  56. 8.10.1 Ameco Medical Company Information
  57. 8.10.2 Ameco Medical Business Overview
  58. 8.10.3 Ameco Medical Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ameco Medical Central Vascular Access Device Product Portfolio
  60. 8.10.5 Ameco Medical Recent Developments
  61. 8.11 AngioDynamics
  62. 8.11.1 AngioDynamics Company Information
  63. 8.11.2 AngioDynamics Business Overview
  64. 8.11.3 AngioDynamics Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AngioDynamics Central Vascular Access Device Product Portfolio
  66. 8.11.5 AngioDynamics Recent Developments
  67. 8.12 Romsons
  68. 8.12.1 Romsons Company Information
  69. 8.12.2 Romsons Business Overview
  70. 8.12.3 Romsons Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Romsons Central Vascular Access Device Product Portfolio
  72. 8.12.5 Romsons Recent Developments
  73. 8.13 PRODIMED
  74. 8.13.1 PRODIMED Company Information
  75. 8.13.2 PRODIMED Business Overview
  76. 8.13.3 PRODIMED Central Vascular Access Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 PRODIMED Central Vascular Access Device Product Portfolio
  78. 8.13.5 PRODIMED Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Central Vascular Access Device Value Chain Analysis
  2. 9.1.1 Central Vascular Access Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Central Vascular Access Device Sales Mode & Process
  6. 9.2 Central Vascular Access Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Central Vascular Access Device Distributors
  9. 9.2.3 Central Vascular Access Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst